参考文献/References:
[1] Abrams P, Baranowski A, Berger RE, et al. A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients? [J]. J Urol, 2006, 175(6): 1989-1990.
[2] Shao Y, Lu GL, Shen ZJ, et al. Reduction of intercellular adhesion molecule 1 May play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis[J]. World J Urol, 2013, 31(3): 535-540.
[3] Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome committee of the international consultation on incontinence [J]. Neurourol Urodyn, 2010, 29(1): 191-198.
[4] Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States[J]. J Urol, 2011, 186(2): 540-544.
[5] Bosch PC, Bosch DC. Treating interstitial cystitis/bladder pain syndrome as a chronic disease[J]. Rev Urol, 2014, 16(2): 83-87.
[6] Lavelle JP, Meyers SA, Ruiz WG, et al. Urothelial pathophysiological changes in feline interstitial cystitis: a human model[J]. Am J Physiol Renal Physiol, 2000, 278(4): F540-F553.
[7] Buffington CA. Idiopathic cystitis in domestic cats--beyond the lower urinary tract[J]. J Vet Intern Med, 2011, 25(4): 784-796.
[8] 梁群超 ,唐兆新 ,郭剑英 .医用酒精性膀胱炎犬模型的建立[J].畜牧与兽医, 2007, 39(9): 77-78.
[9] Westropp JL, Sykes JE, Irom S, et al. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs [J]. J Vet Intern Med, 2012, 26(3): 506-512.
[10] Bayrak O, Erturhan S, Seckiner I, et al. Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder[J]. Urol Ann, 2014, 6(2): 122-126.
[11] Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population[J]. J Urol, 2005, 173(1): 98-102.
[12] Hauser PJ, Buethe DA, Califano J, et al. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate [J]. J Urol, 2009, 182(5): 2477-2482.
[13] Keay S, Leitzell S, Ochrzcin A, et al. A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study[J]. BMC Urol, 2012, 12: 17.
[14] Oottamasathien S, Jia W, Mccoard L, et al. A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides [J]. J Urol, 2011, 186(4 Suppl): 1684-1692.
[15] Wang ZY, Wang P, Bjorling DE. Treatment with a cannabinoid receptor 2 agonist decreases severity of established cystitis [J]. J Urol, 2014, 191(4): 1153-1158.
[16] 吴新华 ,石明 ,刘述成 ,等.小鼠急慢性细菌性膀胱炎模型的制备[J].中华实验外科杂志, 2014, 31(6): 1365-1366.
[17] Bjorling DE, Wang ZY, Boldon K, et al. Bacterial cystitis is accompanied by increased peripheral thermal sensitivity in mice [J]. J Urol, 2008, 179(2): 759-763.
[18] Homan T, Tsuzuki T, Dogishi K, et al. Novel mouse model of chronic inflammatory and overactive bladder by a single intravesical injection of Hydrogen peroxide [J]. J Pharmacol Sci, 2013, 121(4): 327-337.
[19] Lee WY, Savage JR, Zhang J, et al. Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan[J]. PLoS One, 2013, 8 (10): e77854.
[20] Everaerts W, Gees M, Alpizar YA, et al. The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil [J]. Curr Biol, 2011, 21(4): 316-321.
[21] Okinami T, Imamura M, Nishikawa N, et al. Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis[J]. PLoS One, 2014, 9(8): e104216.
[22] Gonzalez RR, Fong T, Belmar N, et al. Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis[J]. J Urol, 2005, 173(2): 630-634.
[23] 杨应华 ,马文儒 ,郑国光 ,等.人源抗菌肽 LL-37[J].生物化学与生物物理进展, 2003, 30(6): 847-851.
[24] Golubeva AV, Zhdanov AV, Mallel G, et al. The mouse cyclophosphamide model of bladder pain syndrome: tissue characterization, immune profiling, and relationship to metabotropic glutamate receptors[J]. Physiol Rep, 2014, 2(3): e00260.
[25] DeBerry JJ, Schwartz ES, Davis BM. TRPA1 mediates bladder hyperalgesia in a mouse model of cystitis [J]. Pain, 2014, 155(7): 1280-1287.
[26] Miki T, Matsunami M, Nakamura S, et al. ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis[J]. Pain, 2011, 152(6): 1373-1381.
[27] Wantuch C1, Piesla M, Leventhal L. Pharmacological validation of a model of cystitis pain in the mouse [J]. Neurosci Lett, 2007, 421 (3): 250-252.
[28] Matsunami, M., T. Miki, K. Nishiura, et al. Involvement of the endogenous hydrogen sulfide/Ca (v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice [J]. Br J Pharmacol, 2012, 167(4):917-928.
[29] Boudes M, Uvin P, Kerselaers S, et al. Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice[J]. Neurourol Urodyn, 2011, 30(8): 1659-1665.
[30] Olivar T, Laird JM. Cyclophosphamide cystitis in mice: behavioural characterisation and correlation with bladder inflammation[J]. Eur J Pain, 1999, 3(2): 141-149.
[31] Lin YH, Liu G, Kavran M, et al. Lower urinary tract phenotype of experimental autoimmune cystitis in mouse: a potential animal model for interstitial cystitis [J]. BJU Int, 2008, 102 (11): 1724-1730.
[32] Singh UP, Singh NP, Guan H, et al. The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment[J]. PLoS One, 2013, 8(11): e79751.
[33] Altuntas CZ, Daneshgari F, Sakalar C, et al. Autoimmunity to uroplakin II causes cystitis in mice: a novel model of interstitial cystitis[J]. Eur Urol, 2012, 61(1): 193-200.
[34] Izgi K, Altuntas CZ, Bicer F, et al. Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice[J]. PLoS One, 2013, 8(8): e72067.
[35] Rudick CN, Bryce PJ, Guichelaar LA, et al. Mast cell-derived histamine mediates cystitis pain[J]. PLoS One, 2008, 3(5): e2096.
[36] Rudick CN, Schaeffer AJ, Klumpp DJ. Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis [J]. BMC Urol, 2009, 9: 16.
[37] Rudick CN, Pavlov VI, Chen MC, et al. Gender specific pelvic pain severity in neurogenic cystitis [J]. J Urol, 2012, 187 (2): 715-724..
[38] Liu W, Deyoung BR, Chen X, et al. RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model [J]. J Autoimmun, 2008, 30(4): 257-265.
[39] Vykhovanets EV, Maclennan GT, Vykhovanets OV, et al. Molecular imaging of nuclear factor-κB in bladder as a primary regulator of inflammatory response [J]. J Urol, 2012, 187 (1): 330-337.
相似文献/References:
[1]周祥福,卢扬柏,湛海伦,等.女性顽固性尿频尿急78例原因分析[J].中华腔镜泌尿外科杂志(电子版),2011,(01):37.
ZHOU Xiang-fu,LU Yang-bai,ZHAN Hai-lun,et al.The reasons of female refractory lower urinary tract symptoms: Report of 78 cases[J].,2011,(06):37.
[2]温世和,陈剑平,欧阳少青,等.膀胱水扩张联合灌注透明质酸钠治疗间质性膀胱炎的临床分析[J].中华腔镜泌尿外科杂志(电子版),2011,(03):228.
WEN Shi-he,CHEN Jian-ping,OU-YANG Shao-qing,et al.Clinical analysis for treatment of interstitial cystitis with bladder hydrodistention and sodium hyaluronate irrigation[J].,2011,(06):228.
[3]刘柏隆,周祥福,杨飞,等.间质性膀胱炎各层组织中神经纤维过表达及其临床意义[J].中华腔镜泌尿外科杂志(电子版),2013,(01):50.
LIU Bo-long,ZHOU Xiang-fu,YANG Fei,et al.The overexpression of nerve fibers in different layers of bladder tissues in patients with interstitial cystitis and their clinical significance[J].,2013,(06):50.
[4]徐汉新,陈华忠,吴兆春,等.抗增殖因子通过下调紧密连接蛋白 Zo-1、 Occludin的表达促进间质性膀胱炎的发生[J].中华腔镜泌尿外科杂志(电子版),2015,(02):131.[doi:10.3877/cma.j.issn.1674-3253.2015.02.013
]
Xu Hanxin,Chen Huazhong,Wu Zhaochun,et al.APF promotes the occurrence of interstitial cystitis through down regulate expression of Zo-1 and occludin[J].,2015,(06):131.[doi:10.3877/cma.j.issn.1674-3253.2015.02.013
]
[5]刘柏隆陈雪莲 湛海伦 张志刚 冯智英 周祥福.间质性膀胱炎的炎症分级与神经纤维密度及临床症状的关系[J].中华腔镜泌尿外科杂志(电子版),2014,(03):171.
Liu Bolong*,Chen Xuelian,Zhan Hailun,et al.The relationship among the grade of inflammation, nerve fibers density and clinical symptoms in patients with interstitial cystitis[J].,2014,(06):171.
[6]徐汉新 陈华忠 吴兆春 刘文彬 杨邦彦 黄海.紧密连接蛋白 Zo-1和 Occludin在间质性膀胱炎中的表达及其作用的研究[J].中华腔镜泌尿外科杂志(电子版),2014,(04):289.[doi:10.3877/cma.j.issn.1674-3253.2014.04.014
]
Xu Hanxin*,Chen Huazhong,Wu Zhaochun,et al.The expression and effect of Zo -1 and Occludin in interstitial cystitis[J].,2014,(06):289.[doi:10.3877/cma.j.issn.1674-3253.2014.04.014
]
[7]李文标,谢俊聪,杨飞,等.尿流动力学检查在间质性膀胱炎/膀胱疼痛综合征诊断与症状评估中的应用[J].中华腔镜泌尿外科杂志(电子版),2017,11(04):268.[doi:10.3877/cma.j.issn.1674-3253.2017.04.013
]
Li Wenbiao,Xie Juncong,Yang Fei,et al.Clinical value of urodynamic testing in diagnosis and symptom assessment of IC/BPS patients[J].,2017,11(06):268.[doi:10.3877/cma.j.issn.1674-3253.2017.04.013
]
[8]谢俊聪,湛海伦,刘柏隆,等.间质性膀胱炎膀胱组织神经纤维密度与尿流动力学的相关性研究[J].中华腔镜泌尿外科杂志(电子版),2017,11(05):326.[doi:10.3877/cma.j.issn.1674-3253.2017.05.009
]
Xie Juncong,Zhan Hailun,Liu Bolong,et al.Relationship between nerve fiber density of bladder tissues and urodynamic tests in patients with interstitial cystitis[J].,2017,11(06):326.[doi:10.3877/cma.j.issn.1674-3253.2017.05.009
]
[9]杨飞,蔡佳荣,李腾成,等.生长相关蛋白-43在间质性膀胱炎患者膀胱黏膜表达的研究[J].中华腔镜泌尿外科杂志(电子版),2018,12(02):86.[doi:10.3877/cma.j.issn.1674-3253.2018.02.005
]
Yang Fei,Cai Jiarong,Li Tengcheng,et al.The expression of growth associated protein 43 in bladder tissue of patients with interstitial cystitis[J].,2018,12(06):86.[doi:10.3877/cma.j.issn.1674-3253.2018.02.005
]